Saturday, July 11, 2026

pharma · Metastatic Breast Cancer

Forward Pharmaceuticals Co

Forward Pharmaceuticals Co clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

Forward Pharmaceuticals Co projects

1 ClinicalTrials.gov programs sponsored by Forward Pharmaceuticals Co.

Forward Pharmaceuticals Co has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. FWD1802

    Forward Pharmaceuticals Co.,

    Metastatic Breast Cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Forward Pharmaceuticals Co have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.